TT Electronics is a global provider of innovative electromagnetic components and sophisticated assemblies for performance-critical applications. The company operates in industries that require perfection including Medical Devices, Aerospace and Defense and Industrial. We have over 50 years of experience in design and manufacturing. Applications that utilize our devices, include:• Implantable Devices• Pacemakers• Defibrillators• Neuromodulators• Minimally Invasive Devices• Navigated Surgical Tools• Sensor-Enabled Diagnostic Devices• External Devices Supporting Implants• Implant Programmers & Charger• Transcutaneous Energy Transfer Systems (TETS)• Left Ventricular Assist (LVA) and Transcranial Magnetic Stimulation (TMS) Devices• Aerospace and Defense• Industrial

Medical Device advisor and Board member service: Lead strategic business planning, new market launch, market research, operations, and KOL development for the innovative medtech companies• Supported JV / Licensing agreement process • Develop C-Suite business strategy; cultivated relationships with companies, and KOLs.• Identify and develop strategies to penetrate most attractive market segments.• Develop pricing strategies to achieve corporate objectives including revenue, market share, and profitability.• Define health economics data required to support successful launch.• Align product specifications and COGS to achieve gross margin, and market share goals.• Align clinical trial objectives with market and healthcare economic needs to optimize revenue potential.

A $2.8B Medical Device company with 17K employees and five business units. The Urology business markets Class II and III products globally.Led turnaround of an underperforming, loss-making organization. Managed $140M P & L.• Developed and launched a new commercial strategy achieving growth 2X to 3X market place growth.• Successfully repositioned company, brands, and products, from tier II to tier I. • Restructured strategy and organization resulting in a 22pt improvement (-3% to +19%) in EBIT.• Turned around the international business from -3% to +24% revenue growth by implementing best practices and restructured product mix.• Developed a new R&D pipeline delivering 60% of total revenue in year three.

Olympus Corporation of America is the healthcare subsidiary of Olympus with $1.6B in revenue and ~2100 employees. Selected by Global Healthcare President to lead the creation of the Respiratory business unit. Developed business strategies and delivered on strategic M&A events while integrating multiple business units.• Led development and re-building of global Respiratory business with revenue of $285M globally and 165 employees.• Developed a 7-year strategic plan, including prioritizing under several disease states, R&D product road maps, early-stage financial investments, and operational restructuring. • Led acquisition of Spiration, an implantable valve for treating emphysema, for $123M.

Following the major acquisition of Gyrus ACMI, appointed CMO to integrate businesses and strategies to drive $1.6B in revenue and $220M operating income for the Medical subsidiary.• Led 100-member marketing organization in the Software, General Surgery, EndoTherapy, GI, Pulmonary, Urology, Repair Services, Training, PR, Marketing Communications, and Trade Show areas.• Successfully integrated four other businesses (Gyrus ACMI, Olympus Surgical, Olympus Latin America, Olympus Canada) into one strategic unit.• Led development of the 5-year Corporate Strategic Plan in collaboration with cross-functional business units.• Implemented best in class customer segmentation strategies, customer-centric product positioning, key opinion leader supported awareness programs, premium brand pricing strategies, and direct to market communications.• Developed several executive-level leaders including VP Sales, VP & GM, Executive Director of Training, Director of International, and US Senior Liaison.

Created and established Olympus as a leader in EndoTherapy. Initiated strategic investments in Sales, Marketing and New Business Development to support company growth plans.● Launched dedicated EndoTherapy business unit. Drove revenue from $12M to over $100M ● Built stand-alone dedicated organization from 4 to 118 employees. ● Built dedicated sales team from 6 to 100 person strong● Established KOLs and Centers of Excellence programs as corner stones to the growth strategy● Created highly successful and differentiated leveraging programs to compete against the market share leader● Successfully negotiated licensing agreements with OEM partners